Lu Li
Stock Analyst at UBS
(1.46)
# 3,505
Out of 5,182 analysts
17
Total ratings
66.67%
Success rate
-3.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Neutral | $370 → $330 | $300.73 | +9.73% | 1 | Apr 13, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $30 → $17 | $12.02 | +41.43% | 5 | Apr 10, 2026 | |
| MYGN Myriad Genetics | Maintains: Neutral | $8 → $6 | $4.84 | +23.97% | 5 | Feb 24, 2026 | |
| VCYT Veracyte | Maintains: Buy | $42 → $48 | $33.43 | +43.58% | 5 | Nov 5, 2025 | |
| FLGT Fulgent Genetics | Upgrades: Buy | $20 → $30 | $15.30 | +96.08% | 1 | Aug 5, 2025 |
Waters
Apr 13, 2026
Maintains: Neutral
Price Target: $370 → $330
Current: $300.73
Upside: +9.73%
QuidelOrtho
Apr 10, 2026
Maintains: Neutral
Price Target: $30 → $17
Current: $12.02
Upside: +41.43%
Myriad Genetics
Feb 24, 2026
Maintains: Neutral
Price Target: $8 → $6
Current: $4.84
Upside: +23.97%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $42 → $48
Current: $33.43
Upside: +43.58%
Fulgent Genetics
Aug 5, 2025
Upgrades: Buy
Price Target: $20 → $30
Current: $15.30
Upside: +96.08%